Table 4.
Cox multivariate regression analyses for the influence of preoperative serum prealbumin on overall survival in 286 elderly ESCC patients with age more than 60 years old and without postoperative adjuvant radiotherapy or chemotherapy
| Variables | Hazard Ratio | P | 95% CI |
|---|---|---|---|
| Overall survival | |||
| Gender(f vs m) | 0.880 | 0.524 | 0.595–1.303 |
| Location(baseline, Proximal esophagus) | 0.262 | ||
| Mid esophagus | 0.967 | 0.931 | 0.456–2.050 |
| Distal esophagus | 0.701 | 0.383 | 0.315–1.557 |
| T stage | 2.026 | <0.001 | 1.382–2.971 |
| N stage | 2.127 | <0.001 | 1.447–3.126 |
| Differentiation(baseline, Well) | 0.042 | ||
| Moderately | 2.606 | 0.065 | 0.943–7.198 |
| Poorly | 3.329 | 0.021 | 1.202–9.218 |
| Prealbumin (baseline, high) | 0.009 | ||
| Low | 1.900 | 0.010 | 1.170–3.085 |
| Median | 1.641 | 0.011 | 1.120–2.404 |
| Albumin(low vs high) | 0.434 | <0.001 | 0.292–0.644 |
Abbreviations: ESCC, esophageal squamous cell carcinoma; CI, confidence interval.